Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas van Groen

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Neurobiology of Disease|March 16, 2018
Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's diseaseJodi R Paul, Hira A Munir, Thomas van Groen, et al.
Neurobiology of Learning and Memory|May 2, 2017
Vitamin A and retinoic acid combination attenuates neonatal hyperoxia-induced neurobehavioral impairment in adult miceManimaran Ramani, Thomas van Groen, Inga Kadish, et al.
Journal of Neuroscience Research|November 26, 2013
Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease miceUlrika Beitnere, Thomas van Groen, Ashish Kumar, et al.
Experimental Gerontology|May 12, 2016
Dietary composition affects the development of cognitive deficits in WT and Tg AD model miceInga Kadish, Ashish Kumar, Ulrika Beitnere, et al.
Behavioural Brain Research|September 21, 2010
Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonismMark P DeAndrade, Fumiaki Yokoi, Thomas van Groen, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer diseasePetra E Spies, Marcel M Verbeek, Thomas van Groen, et al.
Neurobiology of Aging|July 31, 2007
Expression of interleukin-18 is increased in the brains of Alzheimer's disease patientsJohanna Ojala, Irina Alafuzoff, Sanna-Kaisa Herukka, et al.
Scientific Reports|June 20, 2015
Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse modelNicolas Kunath, Thomas van Groen, David B Allison, et al.
BMC Neuroscience|December 4, 2017
Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampusSusan L Campbell, Thomas van Groen, Inga Kadish, et al.
Pharmacological Research|June 28, 2016
Memory-enhancing and brain protein expression-stimulating effects of novel calcium antagonist in Alzheimer's disease transgenic female miceBaiba Jansone, Inga Kadish, Thomas van Groen, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Neurobiology of Disease|March 16, 2018
Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's diseaseJodi R Paul, Hira A Munir, Thomas van Groen, et al.
Neurobiology of Learning and Memory|May 2, 2017
Vitamin A and retinoic acid combination attenuates neonatal hyperoxia-induced neurobehavioral impairment in adult miceManimaran Ramani, Thomas van Groen, Inga Kadish, et al.
Journal of Neuroscience Research|November 26, 2013
Mildronate improves cognition and reduces amyloid-β pathology in transgenic Alzheimer's disease miceUlrika Beitnere, Thomas van Groen, Ashish Kumar, et al.
Experimental Gerontology|May 12, 2016
Dietary composition affects the development of cognitive deficits in WT and Tg AD model miceInga Kadish, Ashish Kumar, Ulrika Beitnere, et al.
Behavioural Brain Research|September 21, 2010
Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonismMark P DeAndrade, Fumiaki Yokoi, Thomas van Groen, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer diseasePetra E Spies, Marcel M Verbeek, Thomas van Groen, et al.
Neurobiology of Aging|July 31, 2007
Expression of interleukin-18 is increased in the brains of Alzheimer's disease patientsJohanna Ojala, Irina Alafuzoff, Sanna-Kaisa Herukka, et al.
Scientific Reports|June 20, 2015
Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse modelNicolas Kunath, Thomas van Groen, David B Allison, et al.
BMC Neuroscience|December 4, 2017
Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampusSusan L Campbell, Thomas van Groen, Inga Kadish, et al.
Pharmacological Research|June 28, 2016
Memory-enhancing and brain protein expression-stimulating effects of novel calcium antagonist in Alzheimer's disease transgenic female miceBaiba Jansone, Inga Kadish, Thomas van Groen, et al.
Pageof 9